Korio

About Korio

Korio is a Randomization and Trial Supply Management (RTSM) platform that enhances clinical trial efficiency by providing flexible, customizable solutions that adapt to complex study designs. It addresses delays and quality issues caused by rigid legacy systems, ensuring timely updates and reliable support throughout the trial process.

```xml <problem> Clinical trials often face delays, quality issues, and excessive costs due to rigid and outdated Randomization and Trial Supply Management (RTSM) systems. These legacy systems struggle to accommodate increasingly complex study designs and on-the-fly updates, leading to frustrating wait times and extensive software customization for each trial. </problem> <solution> Korio offers a flexible and customizable RTSM platform designed to streamline clinical trial processes and prevent common challenges. The platform's modern interface and adaptable architecture allow for easy accommodation of mid-study design updates, minimizing delays and quality issues. Korio's role-based interface empowers various stakeholders, including site users, supply managers, and data managers, to work efficiently and make informed decisions. The platform is built for reliability and quality, offering advanced RTSM functionality without compromising user experience. </solution> <features> - Intuitive, role-based interface for streamlined user experience - Flexible platform designed to accommodate complex study designs and mid-study changes - Centralized platform for randomization and trial supply management - Dedicated project management expertise from study kick-off to closeout - Direct access to leadership team with extensive RTSM experience - Optimized solutions tailored to each client's unique study needs - Automation testing to ensure system quality and impact trial timelines </features> <target_audience> Korio is designed for pharmaceutical companies, biotech firms, and clinical research organizations (CROs) conducting clinical trials who need a flexible, reliable, and modern RTSM platform. </target_audience> ```

What does Korio do?

Korio is a Randomization and Trial Supply Management (RTSM) platform that enhances clinical trial efficiency by providing flexible, customizable solutions that adapt to complex study designs. It addresses delays and quality issues caused by rigid legacy systems, ensuring timely updates and reliable support throughout the trial process.

Where is Korio located?

Korio is based in Doylestown, United States.

When was Korio founded?

Korio was founded in 2021.

How much funding has Korio raised?

Korio has raised $12.3M.

Who founded Korio?

Korio was founded by Chuck Harris.

  • Chuck Harris - Co-founder
Location
Doylestown, United States
Founded
2021
Funding
$12.3M
Employees
26 employees
Investors
Bip VenturesBostonmillennia Partners

Korio

10
Relative Traction Score based on online presence metrics compared to companies in the same age group.

Executive Summary

Korio is a Randomization and Trial Supply Management (RTSM) platform that enhances clinical trial efficiency by providing flexible, customizable solutions that adapt to complex study designs. It addresses delays and quality issues caused by rigid legacy systems, ensuring timely updates and reliable support throughout the trial process.

korioclinical.com1K+
Founded 2021Doylestown, United States

Funding

No specific funding rounds found.

Total Funding

$12.3M

Backed by

Bip VenturesBostonmillennia Partners

Team (25+)

Chuck Harris

Co-founder

Company Description

Problem

Clinical trials often face delays, quality issues, and excessive costs due to rigid and outdated Randomization and Trial Supply Management (RTSM) systems. These legacy systems struggle to accommodate increasingly complex study designs and on-the-fly updates, leading to frustrating wait times and extensive software customization for each trial.

Solution

Korio offers a flexible and customizable RTSM platform designed to streamline clinical trial processes and prevent common challenges. The platform's modern interface and adaptable architecture allow for easy accommodation of mid-study design updates, minimizing delays and quality issues. Korio's role-based interface empowers various stakeholders, including site users, supply managers, and data managers, to work efficiently and make informed decisions. The platform is built for reliability and quality, offering advanced RTSM functionality without compromising user experience.

Features

Intuitive, role-based interface for streamlined user experience

Flexible platform designed to accommodate complex study designs and mid-study changes

Centralized platform for randomization and trial supply management

Dedicated project management expertise from study kick-off to closeout

Direct access to leadership team with extensive RTSM experience

Optimized solutions tailored to each client's unique study needs

Automation testing to ensure system quality and impact trial timelines

Target Audience

Korio is designed for pharmaceutical companies, biotech firms, and clinical research organizations (CROs) conducting clinical trials who need a flexible, reliable, and modern RTSM platform.

Sources:

This profile is AI-generated from web data and may contain inaccuracies. Want to correct or remove an entry? Owners can claim edits via their company email domain, and signed-in users can submit sourced suggestions.